Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-04-22
DOI
https://doi.org/10.1186/s12885-025-14153-5
Citations
1
Primary Topic
Plasma Applications and Diagnostics
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Audrey Glory, Érica Patocskai, Philip W. Wong
1 citations
BMC Cancer
Plasma Applications and Diagnostics
1.36
article

Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Audrey Glory, Érica Patocskai, Philip W. Wong
article en
1 citations

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Centre Hospitalier de l’Université de Montréal (CA)
Ministère de l'Économie, de l’Innovation et des Exportations du Québec
Life in Land
Openalex Percentile: Top 21%
Plasma Applications and Diagnostics
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients — Audrey Glory, Érica Patocskai, et al. · BMC Cancer (2025) | TGRS Research Map | TGRS